Best for
Mobile
How to buy Achieve Life Sciences shares | $8.61
Own Achieve Life Sciences shares in just a few minutes. Share price changes are updated daily.
Achieve Life Sciences, Inc (ACHV) is a leading biotechnology business based in the US. It opened the day at $8.72 after a previous close of $8.66. During the day the price has varied from a low of $8.51 to a high of $8.83. The latest price was $8.61 (25 minute delay). Achieve Life Sciences is listed on the NASDAQ and employs 14 staff. All prices are listed in US Dollars.
How to buy shares in Achieve Life Sciences
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: ACHV in this case.
- Research Achieve Life Sciences shares. The platform should provide the latest information available.
- Buy your Achieve Life Sciences shares. It's that simple.
What's in this guide?
- Can I buy shares in Achieve Life Sciences?
- Has coronavirus impacted Achieve Life Sciences shares?
- Achieve Life Sciences shares summary
- Compare share dealing platforms
- Is Achieve Life Sciences stock a buy or sell?
- Achieve Life Sciences performance over time
- Can I short Achieve Life Sciences shares?
- Achieve Life Sciences's financials
- How volatile are Achieve Life Sciences shares?
- Does Achieve Life Sciences pay a dividend?
- Have Achieve Life Sciences shares ever split?
- Other common questions
How has Coronavirus impacted Achieve Life Sciences's share price?
Since the stock market crash in March caused by coronavirus, Achieve Life Sciences's share price has had significant negative movement.
Its last market close was $8.51, which is 14.90% down on its pre-crash value of $10 (accounting for the 31 July 2020 split) and 88.69% up on the lowest point reached during the March crash when the shares fell as low as $4.51 (accounting for the 31 July 2020 split).
If you had bought $1,000 worth of Achieve Life Sciences shares at the start of February 2020, those shares would have been worth $503.84 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $741.31.
Achieve Life Sciences share price
Use our graph to track the performance of ACHV stocks over time.Achieve Life Sciences shares at a glance
Information last updated 2020-10-06.
| Open | $8.72 |
|---|---|
| High | $8.83 |
| Low | $8.51 |
| Close | $8.61 |
| Previous close | $8.66 |
| Change | $-0.05 |
| Change % | -0.577% |
| Volume | 82,420 |
Information last updated 2020-12-26.
| 52-week range | $0.58 - $18.26 |
|---|---|
| 50-day moving average | $8.3615 |
| 200-day moving average | $8.7954 |
| Wall St. target price | $45 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-2.606 |
Invest in Achieve Life Sciences shares with 0% commission
Other fees may apply. Your capital is at risk.
- Unlimited trades, with no dealing charges or management fees
- If your trades get copied you can earn extra money
- Create an account today in a few minutes
Go to site
Capital at risk
Share dealing platform comparison
Table: sorted by promoted deals first
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is it a good time to buy Achieve Life Sciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Achieve Life Sciences price performance over time
Historical closes compared with the last close of $8.61
| 1 week (2021-01-14) | -5.28% |
|---|---|
| 1 month (2020-12-22) | 13.14% |
| 3 months (2020-10-22) | -4.12% |
| 6 months (2020-07-21) | -20.86% |
| 1 year (2020-01-21) | -29.77% |
|---|---|
| 2 years (2019-01-18) | -67.63% |
| 3 years (2018-01-19) | -70.93% |
| 5 years (2016-01-21) | -37.61% |
Achieve Life Sciences financials
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -42.31% |
| Return on equity TTM | -78.07% |
| Profit margin | 0% |
| Book value | $7.1 |
| Market capitalisation | $48.6 million |
TTM: trailing 12 months
How to short and sell Achieve Life Sciences shares
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "ACHV.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 497,444 Achieve Life Sciences shares held short by investors – that's known as Achieve Life Sciences's "short interest". This figure is 6% down from 528,984 last month.
There are a few different ways that this level of interest in shorting Achieve Life Sciences shares can be evaluated.
Achieve Life Sciences's "short interest ratio" (SIR)
Achieve Life Sciences's "short interest ratio" (SIR) is the quantity of Achieve Life Sciences shares currently shorted divided by the average quantity of Achieve Life Sciences shares traded daily (recently around 352797.16312057). Achieve Life Sciences's SIR currently stands at 1.41. In other words for every 100,000 Achieve Life Sciences shares traded daily on the market, roughly 1410 shares are currently held short.
However Achieve Life Sciences's short interest can also be evaluated against the total number of Achieve Life Sciences shares, or, against the total number of tradable Achieve Life Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Achieve Life Sciences's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Achieve Life Sciences shares in existence, roughly 80 shares are currently held short) or 0.0819% of the tradable shares (for every 100,000 tradable Achieve Life Sciences shares, roughly 82 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Achieve Life Sciences.
Find out more about how you can short Achieve Life Sciences stock.
Achieve Life Sciences share dividends
We're not expecting Achieve Life Sciences to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Have Achieve Life Sciences's shares ever split?
Achieve Life Sciences's shares were split on a 1:20 basis on 31 July 2020. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Achieve Life Sciences shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Achieve Life Sciences shares which in turn could have impacted Achieve Life Sciences's share price.
Achieve Life Sciences share price volatility
Over the last 12 months, Achieve Life Sciences's shares have ranged in value from as little as $0.58 up to $18.26. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Achieve Life Sciences's is 1.4243. This would suggest that Achieve Life Sciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Win £500 to get your trading started
Subscribe to trending stock alerts for a chance to win
Achieve Life Sciences overview
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation aids in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
Frequently asked questions
More guides on Finder
-
How to buy Achieve Life Sciences shares
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Charlie’s Holdings shares
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Lemonade shares | $50.05
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Unity Software shares | $111.51
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
-
How to buy FuelCell Energy shares | $3.745
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Achieve Life Sciences shares | $0.1275
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
-
How to buy Zomedica Pharmaceuticals shares | $0.93
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
-
How to buy YRC Worldwide shares | $4.66
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
-
How to buy Xeros Technology Group shares | 220p
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
-
How to buy Xpediator shares | 33.5p
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
Ask an Expert